The Role of Nutrition in Muscle Function of Bariatric Surgery Patients

NCT ID: NCT06680492

Last Updated: 2024-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-23

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current recommendations for protein intake after bariatric surgery are not based on strong scientific evidence. It remains unclear how much protein should be eaten to minimize muscle loss and preserve the metabolism and function of individuals post-bariatric surgery.

The objective of this study is to analyze the relationships between changes in body composition, nutrition and protein intake, and muscle function after bariatric surgery to further our understanding of the nutritional needs of patients after bariatric surgery.

We intend to recruit around 75 participants, men and women, aged between 18 and 65 years. Participants will be recruited from the Bariatric Surgery Clinic, McGill University Health Center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity, Diabetes, Nutrition, Physical Health Body Composition Changes Muscle Function, Handgrip Strength Test Protein Metabolism Bariatric Surgery Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female
* Aged 18 to 65 years old
* Undergoing first bariatric surgery (any type)
* Diabetics and non-diabetics
* Non-smokers and non-cannabis consumers

Exclusion Criteria

* Pregnant and breastfeeding women
* Individuals undergoing second bariatric surgery
* Regular smokers and cannabis consumers
* Current use of Ozempic (or Ozempic-like medication) and anti-psychotic meds
* Limited physical mobility (using walking aids such as canes, walkers, or wheelchairs) and issues with hand resistance
* Kidney disease, non-controlled / unstable hypertension and hypothyroidism, and any metabolic disease other than diabetes
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Montreal General Hospital

OTHER

Sponsor Role collaborator

Concordia University, Montreal

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sylvia Santosa

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montreal General Hospital (MUHC)

Montreal, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sylvia Santosa, PhD, R.D.

Role: CONTACT

514-848-2424 ext. x5841

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

José A. Morais, M.D., PhD

Role: primary

514-843-1665

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

90000088

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.